Reputation Matters
Insight and analysis by Julio Romo on how perception, reputation and trust shape access to capital, partners and policy.
Is Reputation Risk Holding Back UK Defence Investment?
US investors now fund 47% of European defence tech. Rules are not what is holding UK defence investment back. Perception and reputational risk is, and it is costing Britain and Europe ownership of its own security.
Wake the Money Up: Japan’s Signal to UK and City of London
At Japan Day in London, Ambassador Hiroshi Suzuki said Japan needs to "wake the money up." This article examines the signals behind Japan's ¥373 trillion growth strategy, what the UK can learn from Japanese corporate innovation, and why soft power may be the missing piece in Japan's investment narrative.
UK Wealth Exodus? What the Data Really Shows
Recent media headlines say billions in wealth have left the UK. Yet HMRC, Tax List and city-ranking data show what is moving, what is staying and why it matters. The data is different to the narrative, and the narrative is painting a negative picture of the UK.
Why Defence Investment Shouldn't Be Treated as a Sin Stock
Defence secures the world we live in and has quietly fuelled decades of innovation and growth. Yet for too long, it has carried a reputation it does not deserve and is making us vulnerable to hostile states.
Why Sovereign Wealth Funds Are Becoming GPs
Sovereign wealth funds are quietly building their own asset-management platforms. They are becoming the GPs they used to fund, not just the LPs behind them. What is the impact of this move?
Corporate Venture Capital: The Human Innovation Gap
Two days at the Global Corporate Venturing Symposium in London confirmed something I have believed for years: the biggest barrier to innovation in investment, defence, and deep tech is not the technology. It is the risk-averse culture inside the institutions that should be accelerating it. Here is what the signals said, and why it matters now.
Why Corporate Venture Capital Is Doing What VC Cannot
Corporate venture capital is outperforming traditional VC where it counts most, not on returns, but on survival, commercialisation, and scale. Here is why the cheque is the least important thing a CVC brings.
Why Now Is the Moment to Invest in UK Life Sciences Sector
The UK life sciences sector is backed by world-class science, £520 million in government commitments, and new private market infrastructure. So why is 94% of late-stage capital still coming from overseas?
Why Bond Markets Are Not the Enemy of Governments
Bond markets are not the enemy of governments. They are the trustees of other people's futures, and they are asking one question that too many policy teams are failing to answer.